- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
5. For regulation 18 (wholesale dealing in medicinal products) substitute—
18.—(1) A person may not except in accordance with a licence (a “wholesale dealer’s licence”)—
(a)distribute a medicinal product by way of wholesale dealing; or
(b)possess a medicinal product for the purpose of such distribution.
(2) Paragraph (1)—
(a)does not apply—
(i)to anything done in relation to a medicinal product by the holder of a manufacturer’s licence in respect of that product,
(ii)where the product concerned is an investigational medicinal product, or
(iii)if the product is a radiopharmaceutical in which the radionuclide is in the form of a sealed source; and
(b)is subject to regulation 19.
(3) Distribution of a medicinal product by way of wholesale dealing, or possession for the purpose of such distribution, is not to be taken to be in accordance with a wholesale dealer’s licence unless the distribution is carried on, or as the case may be the product held, at premises located in the UK and specified in the licence.
(4) In these Regulations a reference to distributing a product by way of wholesale dealing is a reference to—
(a)selling or supplying it; or
(b)procuring or holding it or exporting it for the purposes of sale or supply,
to a person who receives it for a purpose within paragraph (5).
(5) Those purposes are—
(a)selling or supplying the product; or
(b)administering it or causing it to be administered to one or more human beings,
in the course of a business carried on by that person.
(6) A wholesale dealer’s licence does not authorise the distribution of a medicinal product by way of wholesale dealing, or possession for the purpose of such distribution, unless a marketing authorisation, Article 126a authorisation, certificate of registration or traditional herbal registration is in force in respect of the product but this—
(a)does not apply in relation to distribution by a person to a person in a third country; and
(b)is subject to the exceptions in regulation 43(6).
(7) In paragraph (6), “marketing authorisation” means—
(a)a marketing authorisation issued by a competent authority of a member State in accordance with the 2001 Directive; or
(b)an EU marketing authorisation.”
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: